Security
HeartSciences Inc. Warrant · HSCSW
HSCSWNASDAQWarrantCurrentCIK 1468492Updated Oct 12, 2026
Name history
Heart Test Laboratories, Inc. · through Oct 18, 2024
HSCSW price & chart
Loading TradingView…
NASDAQ:HSCSW on TradingView ↗About the company
HeartSciences is a healthcare information technology company advancing the use of ECG/EKGs through the integration of artificial intelligence. HeartSciences’ MyoVista Insights™ Platform is a cloud-native, vendor- and device-agnostic ECG management system designed to modernize ECG workflows and improve clinical efficiency and decision-making. The platform’s AI-ECG marketplace is designed to deliver AI-ECG algorithms into clinical workflows across a health system’s existing ECG equipment.
In the news
No coverage from other publishers is available.
Recent filings
Financials
FY 2026 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 5,262,673Source | 4,222,909Source | 9,503,113Source | 3,287,233Source |
| Property, Plant and Equipment, NetUSD | 39,312Source | 63,549Source | 97,991Source | 61,428Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,656,814Source | 1,098,098Source | 5,807,648Source | 1,660,467Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 0Source | 4,350Source | — | — |
| Inventory, NetUSD | 655,629Source | 650,267Source | 629,179Source | 676,359Source |
| Assets, CurrentUSD | 2,582,928Source | 2,171,457Source | 7,353,893Source | 2,696,581Source |
| Operating Lease, Right-of-Use AssetUSD | 268,067Source | 371,626Source | 461,983Source | 529,224Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 5,036,613Source | 4,017,738Source | 2,185,812Source | 3,056,676Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | — | — | 381Source |
| Common Stock, Value, IssuedUSD | 3,188Source | 1,119Source | 677Source | 10,118Source |
| Additional Paid in CapitalUSD | 85,491,469Source | 76,331,307Source | 74,678,650Source | 60,977,256Source |
| Retained Earnings (Accumulated Deficit)USD | -85,269,510Source | -76,127,635Source | -67,362,406Source | -60,757,198Source |
| Stockholders' Equity Attributable to ParentUSD | 226,060Source | 205,171Source | 7,317,301Source | 230,557Source |
| Liabilities and EquityUSD | 5,262,673Source | 4,222,909Source | 9,503,113Source | 3,287,233Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 4,861,112Source | 3,703,211Source | 1,751,767Source | 1,832,891Source |
| Operating Lease, Liability, CurrentUSD | 139,026Source | 119,518Source | 102,293Source | 29,535Source |
| Accounts Payable, CurrentUSD | 318,327Source | 318,661Source | 448,183Source | 631,369Source |
| Operating Lease, Liability, NoncurrentUSD | 175,501Source | 314,527Source | 434,045Source | 536,335Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | — | 506,307Source | 398,331Source | 623,391Source |
cash flow · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,312,383Source | 249,884Source | 405,025Source | 248,308Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -4,350Source | 4,350Source | — | -2,321Source |
| Increase (Decrease) in InventoriesUSD | 5,362Source | 21,088Source | -47,180Source | 2,220Source |
| Increase (Decrease) in Accounts PayableUSD | -334Source | -129,522Source | -183,186Source | 37,824Source |
| Deferred Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -7,426,707Source | -7,412,994Source | -6,070,185Source | -5,773,577Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -44,452Source | -30,188Source | -125,271Source | -18,308Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 3,554Source | 3,157Source | 64,455Source | 18,308Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 8,029,875Source | 2,733,632Source | 10,342,637Source | 6,534,092Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 558,716Source | -4,709,550Source | 4,147,181Source | 742,207Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | 1,098,098Source | 5,807,648Source | 1,660,467Source |
| Additional Financial Items | ||||
| Amortization of Debt Issuance Costs and DiscountsUSD | 495,950Source | 285,870Source | 103,595Source | 61,381Source |
| Capitalized Computer Software, AmortizationUSD | 0Source | — | — | — |
| DepreciationUSD | 27,791Source | 37,599Source | 27,892Source | 26,915Source |
| Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| InterestExpenseNonoperatingUSD | 753,041Source | 500,453Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -9,141,875Source | -8,765,229Source | -6,605,208Source | -6,354,290Source |
| Nonoperating Income (Expense)USD | -729,008Source | -412,658Source | -299,438Source | -241,326Source |
| Operating ExpensesUSD | 8,415,418Source | 8,355,041Source | 6,318,289Source | 6,115,318Source |
| Operating Lease, ExpenseUSD | 200,000Source | — | — | — |
| Other Nonoperating Income (Expense)USD | 24,033Source | — | — | — |
| Proceeds from Contributed CapitalUSD | 0Source | — | 334,249Source | — |
| Proceeds from Issuance of Common StockUSD | 172,839Source | — | — | 5,194,740Source |
income statement · annual statements
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total RevenueUSD | 4,319Source | 4,350Source | 18,600Source | 5,150Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 5,576,406Source | 3,968,936Source | 3,439,735Source | 3,654,450Source |
| Operating Income (Loss)USD | -8,412,867Source | -8,352,571Source | -6,305,770Source | -6,112,964Source |
| Other Nonoperating Income (Expense)USD | 24,033Source | — | — | — |
| Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -9,141,875Source | -8,765,229Source | -6,605,208Source | -6,354,290Source |
| Earnings Per Share, BasicUSD per share | -3.48Source | -9.34Source | -19Source | -0.8Source |
| Earnings Per Share, DilutedUSD per share | — | -9.34Source | -19Source | -0.8Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 2,625,421Source | 938,257Source | 352,520Source | 7,950,550Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | 938,257Source | 352,520Source | 7,950,550Source |
| Interest Expense (non-operating)USD | 753,041Source | 500,453Source | — | — |
| Additional Financial Items | ||||
| Capitalized Computer Software, AmortizationUSD | 0Source | — | — | — |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | 0Source | — | — | — |
| Current Income Tax Expense (Benefit)USD | 0Source | — | — | — |
| Gross ProfitUSD | 2,551Source | 2,470Source | 12,519Source | 2,354Source |
| Interest ExpenseUSD | — | — | 354,080Source | 243,174Source |
| Nonoperating Income (Expense)USD | -729,008Source | -412,658Source | -299,438Source | -241,326Source |
| Operating ExpensesUSD | 8,415,418Source | 8,355,041Source | 6,318,289Source | 6,115,318Source |
| Operating Lease, ExpenseUSD | 200,000Source | — | — | — |
| Research and Development ExpenseUSD | 2,839,012Source | 4,386,105Source | 2,878,554Source | 2,460,868Source |
Offerings
Registration 333-299147
Filing attachments
ea030780201ex99-1.htm · DEFA14A · 2026-10-06
Exhibit 99.1 HeartSciences Receives FDA 510(k) Clearance for its MyoVista ® wav ECG TM Device Southlake, TX, October 6, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), today announced that the U.S. Food and Drug Administration (“FDA”) has granted 510(k) clearance (K260005) f…
Read attachment ↗ea030780201ex99-1.htm · 8-K · 2026-10-06
Exhibit 99.1 HeartSciences Receives FDA 510(k) Clearance for its MyoVista ® wav ECG TM Device Southlake, TX, October 6, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the integration of artificial intelligence (“AI”), today announced that the U.S. Food and Drug Administration (“FDA”) has granted 510(k) clearance (K260005) f…
Read attachment ↗ea030665601ex4-21.htm · S-3 · 2026-09-25
Exhibit 4.21 HEARTSCIENCES INC. Issuer AND [ ] Trustee INDENTURE Dated as of [ ] Senior Debt Securities CROSS-REFERENCE TABLE (1) Section of Trust Indenture Act of 1939, as Amended Section of Indenture ──────────────────────────────────────────────────────────────────────── 310(a). 7.09 310(b). 7.08 …
Read attachment ↗ea030665601ex4-22.htm · S-3 · 2026-09-25
Exhibit 4.22 HEARTSCIENCES INC. Issuer AND [ ] Trustee INDENTURE Dated as of [ ] Subordinated Debt Securities CROSS-REFERENCE TABLE (1) Section of Trust Indenture Act of 1939, as Amended Section of Indenture ──────────────────────────────────────────────────────────────────────────────── 310(a). 7.09 310(b). 7.08 7.10 310(c). In…
Read attachment ↗ea030580201ex99-1.htm · DEFA14A · 2026-09-17
EX-99.1 2 ea030580201ex99-1.htm PRESS RELEASE, DATED SEPTEMBER 17, 2026. Exhibit 99.1 PRESS RELEASE Fortitude Appoints Jaime Leverton as Chief Executive Officer Former Hut 8 CEO to Lead Fortitude as the Zcash-Focused, Vertically-Integrated Mining Platform Advances Toward the Public Markets; Andrea Childs to Transition to Chief Operating Officer Fairport, N.Y., September 17, 2026 - Fortitude Mining Holdings, Inc. (“Fortitude”), a vertically-integrated digital asset mining platform ancho…
Read attachment ↗ea030580201ex99-1.htm · 8-K · 2026-09-17
EX-99.1 2 ea030580201ex99-1.htm PRESS RELEASE, DATED SEPTEMBER 17, 2026. Exhibit 99.1 PRESS RELEASE Fortitude Appoints Jaime Leverton as Chief Executive Officer Former Hut 8 CEO to Lead Fortitude as the Zcash-Focused, Vertically-Integrated Mining Platform Advances Toward the Public Markets; Andrea Childs to Transition to Chief Operating Officer Fairport, N.Y., September 17, 2026 - Fortitude Mining Holdings, Inc. (“Fortitude”), a vertically-integrated digital asset mining platform ancho…
Read attachment ↗